Compare Duolingo Inc (DUOL) vs Oscar Health Inc (OSCR) Price & Performance

Duolingo (DUOL) trades at $132.34, up 6.08% in the last session, reflecting strong momentum. The stock shows bullish technical signals with support at $127 and resistance at $135. Fundamentally, revenue grew to $1.04 billion in 2025, with net income surging to $414 million, driven by robust user engagement and AI feature expansion. Recent earnings beats and a positive analyst consensus highlight investor confidence in the company's growth trajectory.

Outlook remains positive with AI-driven user growth and profitability, but risks include rising inference costs and competitive pressures. The stock offers growth potential, yet investors should monitor margin trends and market volatility. Analyst price targets suggest moderate upside from current levels, with a consensus of $108.29.

OSCR trades at $31.60, up 3.47% today, showing strong momentum near recent highs. The stock exhibits a bullish technical outlook with positive moving average signals and support at $31. Recent Q1 2026 earnings beat expectations with $2.07 EPS versus $1.21 expected, though the company remains unprofitable with a -0.3% net margin. Revenue growth is robust, projected to increase from $11.70B in 2025 to $13.30B in 2026, while operating cash flow strengthens significantly.

The outlook is mixed: strong revenue growth and cash flow improvements support upside potential, but persistent losses and high P/B ratio of 5.63 pose risks. Analyst consensus is cautious with a $22.50 price target below current levels, though technical momentum suggests near-term strength. Key risks include execution on profitability goals and competitive pressures in the health insurance sector.